STA
XRAY icon

Summit Trail Advisors’s Dentsply Sirona XRAY Stock Holding History

Summit Trail Advisors’s Portfolio XRAY Stock Details XRAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$745K Buy
64,258
+11,298
+21% +$141K 0.01% 1034
2025
Q4 		$611K Buy
52,960
+3,579
+7% +$42K 0.01% 1018
2025
Q3 		$632K Buy
+49,381
New +$717K 0.01% 1009
2024
Q4 		– Sell
-9,922
Closed -$270K – 794
2024
Q3 		$270K Sell
9,922
-333
-3% -$8.5K 0.01% 581
2024
Q2 		$256K Buy
+10,255
New +$294K 0.01% 526
2018
Q3 		– Sell
-190
Closed -$8K – 458
2018
Q2 		$8K Buy
+190
New +$8.92K ﹤0.01% 444
2018
Q1 		– Sell
-3,544
Closed -$226K – 1691
2017
Q4 		$226K Buy
+3,544
New +$225K 0.03% 387

Other funds holding XRAY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Summit Trail Advisors's XRAY Position: Q1 2026 in Review

Summit Trail Advisors increased its Dentsply Sirona (XRAY) stake by 21% in Q1 2026, buying an estimated $141K and bringing the position to 64,258 shares worth $745K. The position accounts for 0.01% of the portfolio, ranked #1034.

Summit Trail Advisors first reported a position in XRAY in Q4 2017 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold XRAY as of Q1 2026.

  • Summit Trail Advisors held 64,258 shares of Dentsply Sirona worth $745K as of Q1 2026.
  • Summit Trail Advisors bought 11,298 Dentsply Sirona shares in Q1 2026, an estimated $141K.
  • Dentsply Sirona made up 0.01% of Summit Trail Advisors's portfolio in Q1 2026, its #1034 holding.
  • Summit Trail Advisors first reported a position in Dentsply Sirona in Q4 2017 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held Dentsply Sirona as of Q1 2026.

Based on Summit Trail Advisors's 13F filing for Q1 2026, filed 12 May 2026.